leadf
logo-loader
viewMarrone Bio Innovations

Marrone Bio and Rizobacter to distribute foliar fertilizer and plant health technology in Argentina, Uruguay, Paraguay and Bolivia

With 43 years of history in the South American market, Rizobacter is well-placed to meet the increasing biological demands of growers with its revolutionary plant health product

Marrone Bio
Demand for biologicals is increasing in the region with an estimated market value of US$1 billion

Marrone Bio Innovations Inc (NASDAQ:MBII) and Rizobacter, a subsidiary of Bioceres Crop Solutions Corp (NYSE:BIOX), have announced the signing of an exclusive agreement to distribute foliar fertilizer and plant health technology in Argentina, Uruguay, Paraguay and Bolivia.

South America is well-known for its extensive soybean, corn and wheat production – crops where Marrone Bio’s technology will be an important tool in helping growers increase yield through improved nutrition and plant health. 

Demand for biologicals is increasing in the region with an estimated market value of US$1 billion and a projected CAGR of 11%. Adoption of inoculants, biostimulants and biopesticides is rapidly growing, driven by increased farmer awareness and consumer demand for more environmentally sustainable agricultural practices.

READ: Marrone Bio posts rosy 2Q results as sales of biologicals continue to grow

With 43 years of history and a renowned reputation in the South American market, Rizobacter is well-placed to meet the increasing biological demands of growers with this revolutionary plant health product. 

“Rizobacter has a strong focus in biologicals and sustainable crop solutions. Our portfolio includes inoculants, soil-applied specialty fertilizers and adjuvants for enhanced foliar applications. This alliance enriches our offering of an integrated crop nutrition program,” said Rizobacter CEO Ricardo Yapur in a statement Tuesday.  

Matti Tiainen, co-founder of Pro Farm, a wholly owned subsidiary of Marrone Bio, said that “Rizobacter’s understanding of local growers’ needs, strong distribution network and exceptional talent make them an excellent partner that will allow us to bring biological solutions to more farmers globally.”

The alliance between Rizobacter and Marrone Bio marries complementary portfolios and a strong commitment to research. The result will provide farmers in Argentina, Uruguay, Paraguay and Bolivia with a new solution that will add value to their farming operations.

The product announcement and availability is expected in October 2020.

Based in Davis, California, Marrone Bio holds more than 400 issued and pending patents and has brought six US Environmental Protection Agency-registered biological product lines and one biostimulant to market. 

Contact the author: [email protected]

Follow him on Twitter @PatrickMGraham

Quick facts: Marrone Bio Innovations

Price: 1.22 USD

NASDAQ:MBII
Market: NASDAQ
Market Cap: $186.02 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Marrone Bio Innovations named herein, including the promotion by the Company of Marrone Bio Innovations in any Content on the Site, the Company...

FOR OUR FULL DISCLAIMER CLICK HERE

Marrone Bio Innovations announces alliance with South American company...

Marrone Bio Innovations (NASDAQ: MBII) Chief Commerical Officer Kevin Hammill joined Steve Darling from Proactive to share news the company has taken a step forward on global expansion by announcing an alliance with the South American company Rizobacter to distribute novel plant health and crop...

on 09/25/2020

2 min read